Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 07-2014 | 06-2014 | 04-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,032 | -2 | -173 | -10 | -30 |
| Depreciation Amortization | 0 | 8 | N/A | 5 | N/A |
| Accounts receivable | N/A | -1 | N/A | -10 | N/A |
| Other Working Capital | 79 | 5 | -189 | 4 | 30 |
| Other Operating Activity | 0 | -3 | 0 | 10 | 0 |
| Operating Cash Flow | $-953 | $7 | $-362 | $-1 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -68 | N/A | N/A | N/A |
| Investing Cash Flow | $-12 | $-68 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 50 | N/A | N/A | N/A |
| Debt Repayment | N/A | -17 | N/A | -12 | N/A |
| Common Stock Issued | 1,990 | N/A | 890 | N/A | N/A |
| Other Financing Activity | 0 | 15 | 0 | 11 | 0 |
| Financing Cash Flow | $1,990 | $48 | $890 | $-1 | $N/A |
| Beginning Cash Position | N/A | 52 | N/A | 52 | N/A |
| End Cash Position | 1,025 | 39 | 529 | 50 | N/A |
| Net Cash Flow | $1,025 | $-13 | $529 | $-2 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -953 | 7 | -362 | -1 | N/A |
| Capital Expenditure | -12 | -68 | N/A | N/A | N/A |
| Free Cash Flow | -965 | -61 | -362 | -1 | 0 |